Cubist Pharmaceuticals, Inc. Appoints Mark H.N. Corrigan, M.D., to Its Board of Directors

25 Jun 2008

·www.biospace.com

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the appointment of Mark H.N. Corrigan, M.D., to its Board of Directors. Dr. Corrigan is Executive Vice President, Research & Development at Sepracor, Inc. He also serves on the board of NeuroMed Technologies, Inc.

Organizations

Neuromed Pharmaceuticals Ltd.

Sumitomo Pharma America, Inc.

Cubist Pharmaceuticals LLC

Indications

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.